SPDR S&P Pharmaceuticals ETF (XPH) News Today

SPDR S&P Pharmaceuticals ETF logo
$64.46 +0.30 (+0.46%)
As of 02:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SPDR S&P Pharmaceuticals ETF Latest News

XPH - State Street SPDR S&P Pharmaceuticals ETF
XPH: Healthcare Sector Dashboard For October
XPH: Dividendenhistorie, Rendite und Ex-Dividenden-Tag
State Street SPDR S&P Pharmaceuticals ETF (XPH)
These 5 Undervalued ETFs Could Be Bargains Right Now
XPH: Healthcare Dashboard For January
State Street® SPDR® S&P® Pharmaceuticals ETF
XPH: Small-Cap Pharma Turns Higher, At Long Last
5 Biggest Pharmaceutical ETFs in 2025
XPH: Healthcare Dashboard For July
Capture European Growth with This Banking-Focused ETF
SPDR® S&P Regional Banking ETF
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.

SPDR S&P Pharmaceuticals ETF Media Mentions By Week

SPDR S&P Pharmaceuticals ETF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XPH
News Sentiment
▼
0.00

0.67
▲
Average

News Sentiment

SPDR S&P Pharmaceuticals ETF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XPH Articles
This Week
▼
0

0
▲
XPH Articles
Average Week

SPDR S&P Pharmaceuticals ETF Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
Page Views
276
-5%
Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for SPDR S&P Pharmaceuticals ETF dated 10/30/2026.
From Our Partners